Full Text (PDF)
Original Article

The Study of Prevalence of Pulmonary Hypertension in Children with Sickle Cell Disease

Sonal Gore , Sonal Gore1 , Keerti Swarnkar2 , Amar Taksande3

Author Information

Licence:




Pediatric Education and Research 7(1):p 7-11, January-March 2019. | DOI: DOI: https://dx.doi.org/10.21088/per.2321.1644.7119.2

How Cite This Article:


Timeline

Received : N/A         Accepted : N/A          Published : N/A

Abstract

 Objective: To assess the prevalence and the risk factors of pulmonary hypertension in children with sickle cell disease. Methods: Children (age: 3- 15 y) diagnosed with sickle cell disease were included in the study conducted between August 2016 to July 2018. All relevant past history of hospitalisation, crisis (esp. acute chest syndrome crisis), blood transfusion and medication history was recorded. A thorough physical examination, blood investigations (CBC and Reticulocyte Count) and 2D Echocardiography was carried out for all the enrolled patients. Results: In this study, 18.57% of the study population was found to have PAH with TRV > 2.5 m/s. No statistically significant co-relation was found between age, gender, religion, anthropometry, blood group type, sickle phenotype, total leukocyte count and PAH. There was a statistically significant association of pulmonary hypertension with low Hb, high reticulocyte count and platelet count, history of repeated hospital admissions and blood transfusions and a positive history of ACS.It was also found that patients who were on hydroxyurea treatment were less likely to develop PAH. Conclusion: One-fourth of pediatric sickle cell disease patients demonstrated presence of pulmonary hypertension. Risk factors like low Hb, elevated platelet and reticulocyte count, repeated number of hospital admissions, episodes of ACS and blood transfusions were significantly associated with an elevated TRV finding on Echocardiography in children with Sickle Cell Disease. Hydroxyurea therapy too played a significant role in this study in reducing the chances of having PAH. These patients need to be monitored and followed-up after treatment to assess need for later treatment

Keywords: Sickle Cell Disease; Pulmonary Hypertension; Doppler Echocardiography; Tricuspid Regurtiant Velocity


References

No records found.


About this article


Cite this article


Licence:




Received Accepted Published
N/A N/A N/A

DOI: DOI: https://dx.doi.org/10.21088/per.2321.1644.7119.2

Keywords


Article Level Metrics

Last Updated

Saturday 07 February 2026, 16:03:54 (IST)


201

Accesses

1
47
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received N/A
Accepted N/A
Published N/A

licence



Access this article



Share